Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02061215 · ClinicalTrials.gov registry record
Study of CMV in Kidney Transplant Recipients
A clinical trial, sponsored by University of Nebraska.
- Terminated
- Registry status
- 7
- Enrollment target
NCT02061215 is a clinical trial that was terminated before completion, run by University of Nebraska. The registered enrollment target is 7 participants.
The verdict
NCT02061215 was terminated before completion, sponsored by University of Nebraska.
- TERMINATED
- Registry status
- 7 participants
- Enrollment target
Study Summary
Using novel CYTOF technology to measure a wide array of innate and adaptive cell proportions and cytokine levels, we plan a pilot study in old (\>/=60 years) and young (20-40 years) renal transplant recipients who are cytomegalovirus (CMV) seropositive (regardless of donor serology). Viral load measurements will be performed at baseline prior to transplant (within 1 week),and then at 3, 7 and 10 months after transplant. It is expected that the patient will receive anti-CMV prophylaxis until 6 months post-transplant, so the latter two time points will reflect responses after "release" from antiviral suppression. Each patient will serve as their own control, with comparisons made between measurements at baseline and then at each timepoint. In addition, clinical data will be collected at the time points indicated, particularly renal function and the presence/absence of acute rejection.
Interventions
- OTHER CMV viral load
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2014-04 |
| Est. Completion | 2015-07-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02061215
The ClinicalTrials.gov registry entry for NCT02061215 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CMV viral load is the first listed.
NCT02061215 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02061215 about?
NCT02061215 is a clinical study titled "Study of CMV in Kidney Transplant Recipients". Using novel CYTOF technology to measure a wide array of innate and adaptive cell proportions and cytokine levels, we plan a pilot study in old (\>/=60 years) and young (20-40 years) renal transplant recipients who are cytomegalovirus (CMV) seropositive (regardless of donor serology). Viral load meas...
What is the current status of trial NCT02061215?
This trial is currently terminated. The enrollment target is 7 participants. The study started on 2014-04. Estimated completion is 2015-07-14.
What interventions are being tested in trial NCT02061215?
The interventions under investigation include: CMV viral load (OTHER).
Who is sponsoring clinical trial NCT02061215?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.